Secondary absorbed doses from light ion irradiation in anthropomorphic phantoms representing an adult male and a 10 year old CHILD

Physics in Medicine and Biology

Volumn 55, Issue 22, 2010, Pages 6633-6653

  Hultqvist, Martha ^a   Gudowska, Irena ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBED DOSE; ANTHROPOMORPHIC PHANTOMS; ATOMIC NUMBERS; BEAM LINES; CHARGED FRAGMENTS; DOSE DELIVERY; ENERGY RANGES; LIGHT ION IRRADIATION; LOCAL TUMOR CONTROL; MONTE CARLO SIMULATION; PRIMARY IONS; SECONDARY NEUTRONS; STANDARD DEVIATION; TARGET VOLUMES;

ATOMS; BEAM PLASMA INTERACTIONS; COMPUTER SIMULATION; HEAVY IONS; ION BOMBARDMENT; MONTE CARLO METHODS;

ION BEAMS;

INORGANIC COMPOUND;

ADULT; ARTICLE; CHILD; HUMAN; IMAGE QUALITY; INSTRUMENTATION; MALE; MONTE CARLO METHOD; NEUTRON; RADIATION DOSE; RADIOMETRY;

ADULT; CHILD; HUMANS; INORGANIC CHEMICALS; MALE; MONTE CARLO METHOD; NEUTRONS; PHANTOMS, IMAGING; RADIATION DOSAGE; RADIOMETRY;

EID: 78650023080     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/55/22/004     Document Type: Article

References (54)

1. Agosteo S, Birattari C, CaravaggioM, SilariMand Tosi G 1998 Secondary neutron and photon dose in proton therapy Radiother. Oncol. 48 293-305
2. Agostinelli S et al 2003 G4-a simulation toolkit Nucl. Instrum. Meth. A 506 250-303
3. Allison J et al 2006 GEANT4 developments and applications IEEE T. Nucl. Sci. 53 270-78
4. Battistoni G, Muraro S, Sala P, Cerutti F, Ferrari A, Roesler S, Fasso A and Ranft J 2007 The FLUKA code: description and benchmarking Proc. Hadronic Shower Simulation Workshop 2006, Fermilab (6-8 September 2006) AIP Conf. Proc. vol 896 pp 31-49
5. Blakely E A and Chang P Y 2004 Late effects from Hadron therapy Radiother. Oncol. 73 S134-40
6. Botvina A S, Dementyev A V, Smirnova O N, Sobolevsky N M and Toneev V D 1997 MSDM - Multi Stage Dynamical Model International Codes and Model Intercomparison for Intermediate Energy Activation Yields. NSC/DOC(97)-1, NEA/P&T No 14 (Paris: OECD) p 307
7. Brahme A 2004 Recent advances in light ion radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 58 603-16
8. Brenner D J, Elliston C D, Hall E J and Paganetti H 2009 Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator Phys. Med. Biol. 54 6065-78
9. Brenner D J and Hall E J 2008 Secondary neutrons in clinical proton radiotherapy: a charged issue Radiother. Oncol. 86 165-70
10. Chang J Y, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R and Cox J D 2006 Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensitymodulated radiation therapy in Stage I or Stage III non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 65 1087-96
11. Clasie B, Wroe A, Kooy H, Depauw N, Flanz J, Paganetti H and Rosenfeld A 2010 Assessment of out-of-field absorbed dose and equivalent dose in proton fields Med. Phys. 37 311-21
12. Cristy M 1987 Specific absorbed fractions of energy at various ages from internal photon sources ORNL/TM-8381 (Oak Ridge, TN: Oak Ridge National Laboratory)
13. Dementyev A V and Sobolevsky N M 1997 SHIELD - universal Monte Carlo hadron transport code: scope and applications Proc. 3rd Workshop on Simulating Accelerator Radiation Environments (SARE 3) KEK (Tsukuba, Japan, 7-9 May) ed H Hirayama pp 21-31
14. Ferrari A, Sala P, Fasso A and Ranft J 2005 FLUKA: a multi-particle transport code CERN 6912 Yellow Report CERN 2005-10, INFN/TC 05/11, SLAC-R-773 (Geneva: CERN)
15. Fontenot J D, Lee A K and Newhauser W D 2009 Risk of secondary malignant neoplasms from proton therapy and intensity-modulated X-ray therapy for early-stage prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 74 616-22
16. Geithner O, Andreo P, Sobolevsky N, Hartmann G and Jäkel O 2006 Calculation of stopping power ratios for carbon ion dosimetry Phys. Med. Biol. 51 2279-92
17. Gudowska I, Sobolevsky N, Andreo P, Belkic D and Brahme A 2004 Ion beam transport in tissue-like media using the Monte Carlo code SHIELD-HIT Phys. Med. Biol. 49 1933-58
18. 12C ions in water and their dose contributions in carbon ion radiotherapy New. J. Phys. 10 075003
19. Hultqvist M and Gudowska I 2009 Secondary doses in anthropomorphic phantoms irradiated with light ion beams Nucl. Technol. 168 123-7
20. Hultqvist M and Gudowska I 2010 Secondary doses delivered to an anthropomorphic male phantom under prostate irradiation with proton and carbon ion beams Radiat. Meas. doi:10.1016/j.radmeas.2010.05.020
21. IAEA 2008 Relative biological effectiveness in ion beam therapy IAEA Technical Report Series No 461 (Vienna: International Atomic Energy Agency)
22. ICRP 2007 The 2007 Recommendations of the International Commission on Radiological Protection ICRP Publication 103 (Oxford: Pergamon)
23. Iwase H, Niita K and Nakamura T 2002 Development of general-purpose particle and heavy ion transport Monte Carlo code J. Nucl. Sci. Technol. 39 1142-51
24. Jiang H, Wang B, Xu X G, Suit H D and Paganetti H 2005 Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment Phys. Med. Biol. 50 4337-53
25. Kanai T et al 1999 Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 44 201-10
26. Kusano Y, Kanai T, Kase Y, Matsufuji N, Komori M, Kanematsu N, Ito A and Uchida H 2007 Dose contributions from large-angle scattered particles in therapeutic carbon beams Med. Phys. 34 193-8
27. Mesoloras G, Sandison G A, Stewart R D, Farr J B and Hsi W C 2006 Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother Med. Phys. 33 2479-90
28. Newhauser W D et al 2009 The risk of developing a second cancer after receiving craniospinal proton irradiation Phys. Med. Biol. 54 2277-91
29. Niita K, Sato T, Iwase H, Nose H, Nakashima H and Sihver L 2006 PHITS - a particle and heavy ion transport code system Radiat. Meas. 41 1080-90
30. ORNL 2005 Description of the mathematical phantoms http://ordose.ornl. gov/resources/phantom.html
31. Pelowitz D B 2005 MCNPX user's manual, version 2.5.0 Los Alamos National Laboratory Report LA-CP-05-0369 (Los Alamos, NM: Los Alamos National Laboratory) Online at http://mcnpx.lanl.gov
32. Polf J C, Newhauser W D and Titt U 2005 Patient neutron dose equivalent exposures outside of the proton therapy treatment field Radiat. Prot. Dosim. 115 154-8
33. PTCOG 2010 PTCOG Shielding design and radiation safety of charged particle therapy facilities PTCOG Report 1
34. Rijkee A, Zoetelief J, Raaijmakers C, Marck S and Zee W 2006 Assessment of induction of secondary tumours due to various radiotherapy modalities Radiat. Prot. Dosim. 118 219-26
35. Sato T, Kase Y,Watanabe R, Niita K and Sihver L 2009 Biological dose estimation for charged-particle therapy using an improved PHITS code coupled with a microdosimetric kinetic model Radiat. Res. 171 107-17
36. Schneider U, Agosteo S, Pedroni E and Besserer J 2002 Secondary neutron dose during proton therapy using spot scanning Int. J. Radiat. Oncol. Biol. Phys. 53 244-51
37. Schulz-Ertner D, Nikoghosyan A, Didinger B, Karger C P, Jäkel O, Wannenmacher M and Debus J 2003 Treatment planning intercomparison for spinal chordomas using intensity-modulated photon radiation therapy (IMRT) and carbon ions Phys. Med. Biol. 48 2617-31
38. SHIELD 2010 http://www.inr.ru/shield
39. Shin D, Yoon M, Kwak J, Shin J, Lee S B, Park S Y, Park S, Kim D Y and Cho K H 2009 Secondary neutron doses for several beam configurations for proton therapy Int. J. Radiat. Oncol. Biol. Phys. 74 260-5
40. St ClairWH, Adams J A, Bues M, Fullerton B C, Shell S L, Kooy H M, Loeffler J S and Tarbell N J 2004 Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma Int. J. Radiat. Oncol. Biol. Phys. 58 727-34
41. Sobolevsky N M 2001 The SHIELD transport code: a tool for computer study of interaction of particles and nuclei with complex media Proc. 3rd Yugoslav Nuclear Society Int. Conf. (YUNSC2000) (Belgrade: The VINCA Institute) pp 539-64
42. Sugane T et al 2009 Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer Lung Cancer 64 45-50
43. Taddei P J, Fontenot J D, Zheng Y, Mirkovic D, Lee A K, Titt U and Newhauser W D 2008 Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer Phys. Med. Biol. 53 2131-47 (Pubitemid 351605990)
44. Taddei P J, Mirkovic D, Fontenot J D, Giebeler A, Zheng Y, Kornguth D, Mohan R and Newhauser W D 2009 Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams Phys. Med. Biol. 54 2259-75
45. Tayama R, Fujita Y, Tadokoro M, Fujimaki H, Sakae T and Terunuma T 2006 Measurement of neutron dose distribution for a passive scattering nozzle at the Proton Medical Research Center (PMRC) Nucl. Instrum. Meth. A 564 532-6
46. Wroe A, Rosenfeld A and Schulte R 2007 Out-of-field dose equivalents delivered by proton therapy of prostate cancer Med. Phys. 36 3449-56
47. Xu G X, Bednarz B and Paganetti H 2008 A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction Phys. Med. Biol. 53 R193-241
48. Yan X, Titt U, Koehler A M and Newhauser W D 2002 Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field Nucl. Instrum. Meth. A 476 429-34
49. Yonai S,Matsufuji N and Kanai T 2009 Monte Carlo study on secondary neutrons in passive carbon-ion radiotherapy: identification of the main source and reduction in the secondary neutron dose Med. Phys. 36 4830-39
50. Yonai S et al 2008 Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies Med. Phys. 35 4782-92
51. Yuh G E, Loredo L N, Yonemoto L T, Bush D A, Shahnazi K, Preston W, Slater J M and Slater J D 2004 Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children Cancer J. 10 386-90
52. Zacharatou Jarlskog C, Lee C, Bolch W, Xu X G and Paganetti H 2008 Assessment of organ specific neutron doses in proton therapy using whole-body age-dependent voxel phantoms Phys. Med. Biol. 53 693-714
53. Zacharatou Jarlskog C and Paganetti H 2008 Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age Int. J. Radiat. Oncol. Biol. Phys. 72 228-35
54. Zheng Y, Fontenot J, Taddei P, Mirkovic D and Newhauser W 2008 Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit Phys. Med. Biol. 53 187-201